ARK Genomic Revolution ETF vs Core Scientific Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.54, while Core Scientific Inc trades at $20.7 (market cap $6.35B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Core Scientific Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | CORZ | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $29.16 |
52-Week Low | $24.02 | $13.55 |
Market Cap | — | $6.35B |
Enterprise Value | — | $8.88B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
CORZ trades at $21.30, up 9.57% in the last 24 hours, showing strong momentum despite a bearish technical signal. The stock faces fundamental challenges with a net income margin of -324.9% and negative EPS misses, but recent developments include a significant partnership with AMD for up to 2.5 gigawatts of data center capacity, potentially driving future revenue growth. Analyst sentiment remains overwhelmingly positive with 86% buy ratings and a consensus price target of $35.88.
The outlook for CORZ hinges on executing its AI infrastructure strategy, with the AMD deal offering substantial upside if successfully monetized. Key risks include persistent cash burn, competitive pressures, and reliance on long-term contracts. Investors should weigh the high growth potential against the current lack of profitability and volatile stock performance.
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.
Read more on CORZ →